SLXN

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

About Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Details

Daily high

$2.44

Daily low

$2.27

Price at open

$2.40

52 Week High

$51.75

52 Week Low

$2.13

Market cap

7.4M

Dividend yield

0.00%

Volume

730

Avg. volume

47,513

P/E ratio

-.09

Silexion Therapeutics Corp - Ordinary Shares News